Camelia Quek

Dr. Camelia Quek is an NHMRC Investigator Fellow at Melanoma Institute Australia and Adjunct Associate Professor at the University of Sydney. She holds advanced degrees including a PhD in Neuroscience and Computational Biology (Sawyer Medal, University of Melbourne) and a Bachelor of Advanced Science in Molecular Biology (University Medal, UNSW).

• PhD (Sawyer Medal), University of Melbourne
• BAdvSci (Hons I, University Medal), University of New South Wales
• DipMolBiotech (Gold Medal), Nanyang Polytechnic

Her research focuses on melanoma immunotherapy, single-cell multi-omics, and spatial biology to identify biomarkers of response/resistance and druggable targets. She pioneered tools like iSRAP for small RNA-seq analysis and MIT for spatial multiomics integration.

Recent publications in Nature, Nature Medicine, and Cancer Cell highlight her work on tumor-immune interactions and obesity-melanoma metabolism links. Awards include 2022 CINSW Wildfire Highly Cited Award and 2021 Millennium Science Start Single Cell Award.

• 2023: Best Oral Talk, ISCB ASCS
• 2017: Team award for CINSW Outstanding Cancer Research

Dr. Quek serves as Associate Editor for Molecular Carcinogenesis and Review Editor for Frontiers. She supervises PhD students and chairs progress evaluations while co-investigating international data access initiatives (TCGA/EGA).